Rare diseases
Investigational molecules
Locations
A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
AustriaStudy of IPX203 compared to levodopa/carbidopa in patients with advanced Parkinson's disease and motor fluctuations
ItalyStudy of Navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema
AustriaComparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis
BulgariaStudy of IPN10200 compared to placebo for prevention of episodic or chronic migraine in adults
CzechiaStudy of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis
BulgariaStudy of TAK-279 and apremilast for adults with moderate to severe plaque psoriasis
GermanyStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
AustriaStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
BelgiumStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
BulgariaStudy of Orticumab in Adults with Previous Heart Attack and High Coronary Inflammation Measured by CT Scan
CzechiaLong-term safety and effectiveness study of verekitug injections in adults with severe asthma who completed the VALIANT trial
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
